Cargando…

Change of Fecal Flora and Effectiveness of the Short-term VSL#3 Probiotic Treatment in Patients With Functional Constipation

BACKGROUND/AIMS: We investigated gut flora characteristics in patients with functional constipation (FC) and influences of short-term treatment with VSL#3 probiotic on flora and symptom improvement. METHODS: Thirty patients fulfilling Rome III criteria for FC and 30 controls were enrolled. Fecal sam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Seong-Eun, Choi, Suck Chei, Park, Kyung Sik, Park, Moo In, Shin, Jeong Eun, Lee, Tae Hee, Jung, Kee Wook, Koo, Hoon Sup, Myung, Seung-Jae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Neurogastroenterology and Motility 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288088/ https://www.ncbi.nlm.nih.gov/pubmed/25537674 http://dx.doi.org/10.5056/jnm14048

Ejemplares similares

Practical Treatments for Constipation in Korea
por: Park, Kyung-Sik, et al.
Publicado: (2012)

Constipation Misperception Is Associated With Gender, Marital Status, Treatment Utilization and Constipation Symptoms Experienced
por: Lee, Tae Hee, et al.
Publicado: (2014)

Recent Updates on the Treatment of Constipation
por: Ryu, Han Seung, et al.
Publicado: (2015)

Fecal Microbiota Transplantation Modulates the Gut Flora Favoring Patients With Functional Constipation
por: Zhang, Xueying, et al.
Publicado: (2021)

Comparative genomic analysis of the multispecies probiotic-marketed product VSL#3
por: Douillard, François P., et al.
Publicado: (2018)

Nationwide Multicenter Study for Overlaps of Common Functional Gastrointestinal Disorders in Korean Patients With Constipation
por: Park, Kyung Sik, et al.
Publicado: (2017)

Technique of Functional and Motility Test: How to Perform Biofeedback for Constipation and Fecal Incontinence
por: Lee, Hyo Jeong, et al.
Publicado: (2013)

Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis
por: Dang, Xiaofei, et al.
Publicado: (2020)

Correction: Comparative genomic analysis of the multispecies probiotic-marketed product VSL#3
por: Douillard, François P., et al.
Publicado: (2018)

Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases
por: Cheng, Fang-Shu, et al.
Publicado: (2020)

Probiotic Therapy With VSL#3(®) in Patients With NAFLD: A Randomized Clinical Trial
por: Derosa, Giuseppe, et al.
Publicado: (2022)

Editorial: Probiotics and constipation
por: Song, Jiajia, et al.
Publicado: (2023)

Biofeedback Therapy in Constipation and Fecal Incontinence
por: Myung, Seung-Jae
Publicado: (2010)

Corrigendum to “Probiotic mixture VSL#3: An overview of basic and clinical studies in chronic diseases”
por: Sang, Li-Xuan
Publicado: (2021)

Probiotic colonization dynamics after oral consumption of VSL#3(®) by antibiotic-treated mice
por: Theriot, Casey, et al.
Publicado: (2022)

Probiotics (VSL#3) Prevent Endothelial Dysfunction in Rats with Portal Hypertension: Role of the Angiotensin System
por: Rashid, Sherzad K., et al.
Publicado: (2014)

Amelioration of intestinal and systemic sequelae of murine Campylobacter jejuni infection by probiotic VSL#3 treatment
por: Ekmekciu, Ira, et al.
Publicado: (2017)

The Probiotic Mixture VSL#3 Accelerates Gastric Ulcer Healing by Stimulating Vascular Endothelial Growth Factor
por: Dharmani, Poonam, et al.
Publicado: (2013)

PReS-FINAL-2074: The role of the probiotic VSL-3 as adjuvant therapy in patients with undifferentiated spondyloarthritis (ERA)
por: Vidovic, M, et al.
Publicado: (2013)

Correction: Probiotics (VSL#3) Prevent Endothelial Dysfunction in Rats with Portal Hypertension: Role of the Angiotensin System
Publicado: (2014)

Chronic bacterial prostatitis and irritable bowel syndrome: effectiveness of treatment with rifaximin followed by the probiotic VSL#3
por: Vicari, Enzo, et al.
Publicado: (2014)

Probiotics VSL#3 Protect against Development of Visceral Pain in Murine Model of Irritable Bowel Syndrome
por: Distrutti, Eleonora, et al.
Publicado: (2013)

VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer
por: Arthur, Janelle C., et al.
Publicado: (2013)

The Effect of Tegaserod on Symptoms and Quality of Life in Korean Women with Irritable Bowel Syndrome with Constipation
por: Kim, Yong Sung, et al.
Publicado: (2010)

Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised Edition
por: Shin, Jeong Eun, et al.
Publicado: (2016)

Development of omics‐based protocols for the microbiological characterization of multi‐strain formulations marketed as probiotics: the case of VSL#3
por: Mora, Diego, et al.
Publicado: (2019)

Probiotic VSL#3 Treatment Reduces Colonic Permeability and Abdominal Pain Symptoms in Patients With Irritable Bowel Syndrome
por: Boonma, Prapaporn, et al.
Publicado: (2021)

Correction: The Probiotic Mixture VSL#3 Accelerates Gastric Ulcer Healing by Stimulating Vascular Endothelial Growth Factor
por: Dharmani, Poonam, et al.
Publicado: (2022)

The Long and Winding Road to the Best Clinical Research and Personalized Therapy With Probiotics: Do Not Forget Host Physiology
por: Kim, Yong Sung, et al.
Publicado: (2023)

2022 Seoul Consensus on Clinical Practice Guidelines for Functional Constipation
por: Cho, Young Sin, et al.
Publicado: (2023)

Effects of a multi-strain probiotic on growth, health, and fecal bacterial flora of neonatal dairy calves
por: Guo, Yongqing, et al.
Publicado: (2022)

Modulation of Intestinal Microbiota by the Probiotic VSL#3 Resets Brain Gene Expression and Ameliorates the Age-Related Deficit in LTP
por: Distrutti, Eleonora, et al.
Publicado: (2014)

Role of probiotics VSL#3 in prevention of suspected sepsis in low birthweight infants in India: a randomised controlled trial
por: Sinha, Anju, et al.
Publicado: (2015)

Probiotic mixture VSL#3 reduce high fat diet induced vascular inflammation and atherosclerosis in ApoE(−/−) mice
por: Chan, Yee Kwan, et al.
Publicado: (2016)

The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment
por: Ekmekciu, Ira, et al.
Publicado: (2017)

Successful Surgical Repair of Anterior Rectocele in Patient With Constipation
por: Kim, Ki Su, et al.
Publicado: (2013)

The Fecal Viral Flora of Wild Rodents
por: Phan, Tung G., et al.
Publicado: (2011)

The Probiotic Mixture VSL#3 Dampens LPS-Induced Chemokine Expression in Human Dendritic Cells by Inhibition of STAT-1 Phosphorylation
por: Mariman, Rob, et al.
Publicado: (2014)

Colonic flora, Probiotics, Obesity and Diabetes
por: Marik, Paul E.
Publicado: (2012)

Effect of Biofeedback Therapy in Constipation According to Rectal Sensation
por: Ahn, Ji Yong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4buc9fi91q64qsr1k6ougrbts1